![theranos.jpg](https://assets1.cbsnewsstatic.com/hub/i/r/2016/05/26/2fb5f1f0-5b95-41ce-b37b-7070dbaaf233/thumbnail/640x360/12b21dbe92f36d79d865a5dc734f72ab/theranos.jpg?v=0a0c17d349635d55704afd4e16e28fc6#)
Theranos is now facing a lawsuit alleging consumer fraud
A class-action lawsuit claims the problem-plagued blood-testing company misled consumers
Watch CBS News
Aimee Picchi is associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has been published by national news outlets including USA Today and Consumer Reports. Aimee frequently writes about retirement, and has been a National Press Foundation fellow for reporting on retirement and Columbia University's Age Boom Academy. She's also the editor of the Institutional Investor book "Cultivating the Affluent II," with noted wealth consultant Russ Alan Prince.
A class-action lawsuit claims the problem-plagued blood-testing company misled consumers
Some customers are alleging that the chain replaced their jewels with fakes when they went for repairs
Just three out of 10 cards fully disclose their fees, which could add up to hundreds in annual costs for the unaware
With an espresso bar and kombucha section, the new Los Angeles store hopes to woo price-conscious -- but trendy -- shoppers
A complaint alleges that Brown, Yale and Dartmouth use racial quotas to keep enrollments artificially low
The giant e-tailer will no longer provide refunds in such cases amid a rash of startups that search for price changes
The chain says its reward club members can opt out of its insanely long receipts in favor of digital records
It's now the most common living arrangement for the country's 18-to-34 year olds, a first in modern history
Agrochem giant could draw fire from "Frankenfood" critics, while also needing to pass muster with investors and regulators
Seniors across the U.S. are living on income that financial experts say falls well short of they need for retirement
Workers without bank accounts increasingly rely on the cards to get their pay, but high fees and confusing terms reign
The blood testing start-up has corrected or voided results from 2014 to 2015, raising questions for patients
Monsanto, already a lightning rod for criticism, may become part of a bigger seed and chemical company
More than 4 million Americans will qualify for time-and-a half pay with the U.S. Labor Department's new rule
In a major shift in how fledgling tech companies are funded, average investors can buy stakes in startups -- but buyer beware